Stay updated on Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Sign up to get notified when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.

Latest updates to the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page
- Check5 days agoChange DetectedThe ClinicalTrials.gov error page shows the site revision changing from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study content with an access-denied message. This indicates the study record at this URL is currently inaccessible.SummaryDifference19%

- Check47 days agoChange DetectedA revision label on the page updated from v3.6.5 to v3.6.6, representing a minor version update to the page.SummaryDifference0.1%

- Check68 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a software or UI update to the page.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page footer has been updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a platform/UI update without altering the study information or eligibility details.SummaryDifference0.0%

- Check104 days agoChange DetectedThe page shows a new revision tag at the bottom, indicating an update to the study page (v3.6.3). This is a maintenance update and does not change the study details.SummaryDifference0.0%

Stay in the know with updates to Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Recombinant Prourokinase for Acute Pulmonary Embolism Clinical Trial page.